Pfizer
Peter Goldstein has worked in the pharmaceutical industry for over 40 years, holding various leadership positions at reputable companies. Peter has extensive experience in global marketing and has managed teams and budgets exceeding millions of dollars. Peter's expertise includes developing marketing processes, training programs, and communication plans. Peter has consistently exceeded revenue and growth targets throughout their career.
Peter Goldstein obtained a Bachelor of Business Administration (B.B.A.) degree from UCLA in 1980. Later, they pursued a Master of Business Administration (M.B.A.) degree at China Europe International Business School (CEIBS), which they completed in 2002.
This person is not in the org chart
This person is not in any offices
Pfizer
606 followers
Pfizer Inc. is a research-based, global biopharmaceutical company. They apply science and their global resources to bring therapies to people that extend and significantly improve their lives through the discovery, development, manufacture, marketing, sale and distribution of biopharmaceutical products worldwide. They work across developed and emerging markets to advance wellness, prevention, treatments and cures that challenge the most feared diseases of our time. Pfizer collaborates with healthcare providers, governments and local communities to support and expand access to reliable, affordable healthcare around the world. Pfizer was founded in 1942. Most of Pfizer’s revenues come from the manufacture and sale of biopharmaceutical products. They believe that their medicines and vaccines provide significant value for healthcare providers and patients, through improved treatment of diseases, improvements in health, wellness and productivity as well as by reducing other healthcare costs, such as emergency room or hospitalization. Pfizer is committed to fulfilling their purpose: Breakthroughs that change patients’ lives. Their purpose fuels everything they do and reflects both their passion for science and commitment to patients. Pfizer’s growth strategy is driven by five “Bold Moves” that help them deliver breakthroughs for patients and create value for shareholders and other stakeholders: 1. Unleash the power of our people; 2. Deliver first-in-class science; 3. Transform our go-to-market model; 4. Win the digital race in pharma; and 5. Lead the conversation.